Home

Biomarkers

Alzheimer's Disease

Read time: 3 min

Congress highlights

Which tau biomarkers are most informative in AD?

Aggregates of hyperphosphorylated and C-terminally truncated microtubule-associated tau protein are...

Parkinson's Disease

Read time: 3 min

Congress highlights

Early detection, treatment and the potential for future prevention is the precursor of a new era in Parkinson’s disease

Detecting Parkinson’s disease (PD) early is essential so that therapy may be given as early...

Alzheimer's Disease

Read time: 2 min

Congress highlights

Why do star cells damage neurons in neurodegenerative diseases? New insights into Alzheimer’s disease pathogenesis

Why do star cells damage neurons in neurodegenerative diseases, including Alzheimer’s disease...

Read time: 3 min

Congress highlights

Digital approach to brain disorders needs ethical perspective

With the rapidly expanding frontiers of digital health, as with any move into the/this new...

Alzheimer's Disease

Read time: 2 min

Congress highlights

The emerging relationship between plasma and brain amyloid-β — does it play a role in the pathogenesis in Alzheimer’s disease?

Reliable plasma amyloid-β (Aβ) measurement is now possible using new highly sensitive techniques,...

Parkinson's Disease

Read time: 3 min

Congress highlights

EAN 2019: Research highlights in Parkinson’s disease

During a presentation on “highlights in movement disorders” at the EAN Congress, key...

Depression, Bipolar

Read time: 3 min

Congress highlights

In search of biomarkers for mood disorders

Novel biomarkers for mood disorders will enable early diagnosis and inform the development of new...

Read time: 2 min

Congress highlights

Can inflammatory biomarkers help to personalize depression treatment?

Which treatment is best suited for which type of depression? Patients with a subtype of major...

Read time: 3 min

Congress highlights

What is the role of inflammation in the pathophysiology of mood disorders?

Evidence supporting a role for inflammation and pro-inflammatory mediators in the pathophysiology...

Read time: 3 min

Congress highlights

Biomarkers - the Future of Diagnosis in Psychiatry?

Diagnosis of psychiatric disorders currently depends on clinical criteria. In the future the hope...

Alzheimer's Disease

Read time: 3 min

Congress highlights

Encouraging immune response to AD: adjuvants, modifying the microbiome, and microglial rejuvenation

Modulating central and peripheral innate immunity has potential in Alzheimer’s Disease....

Parkinson's Disease

Read time: 3 min

Congress highlights

What the brain teaches us about α-synuclein

In all affected brain regions, α-synuclein accumulates only in specific cell types, and only in...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country